Alnylam to webcast investor event to discuss results from KARDIA-2 phase 2 study of zilebesiran at American College of Cardiology Scientific Session

Dear Investor,Please find below link to a press release from our partner company Alnylam:https://investors.alnylam.com/press-release?id=28071We kindly invite you to join this investor event on Sunday April 7, 2024 at 7:00 pm ET.Do not hesitate to contact us for any further questions.With best regards,Roche Investor Relations Dr. Bruno EschliPhone: [phone]e-mail:[e-mail] Dr. Sabine Borngr äberPhone: [phone]e-mail:[e-mail] Dr. Birgit MasjostPhone: [phone]e-mail:[e-mail]   Investor Relations North America Loren KalmPhone: [phone]e-mail:[e-mail]  

Source: Roche Investor Update - March 20, 2024 Category: Pharmaceuticals Source Type: news